Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Stock Information for CooTek (Cayman) Inc. American Depositary Shares each representing 650 Class A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CooTek (Cayman) Inc. American Depositary Shares each representing 650 Class A

Guardion Health Sciences Announces Declaration of Cash Distribution
Guardion Health Sciences Announces Filing of Certificate of Dissolution
 Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company's Special Meeting of Stockholders to be held on May 23, 2024
Guardion Health Sciences Announces

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.